Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Italian Real-world Study on Epcoritamab in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

NCT07393204 is registered in ClinicalTrials.gov with Andrés José Maria Ferreri as lead sponsor.

NCT NCT07393204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07393204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Italian Real-world Study on Epcoritamab in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Lead sponsor
Andrés José Maria Ferreri
Phase
Observational
Overall status
Active, not recruiting
Start date
December 10, 2025
Completion date
December 10, 2026
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory diffuse large b-cell lymphoma, relapsed diffuse large b-cell lymphoma (dlbcl)